Evidence map›Paper›PMID 18353279›Full record

ReviewBiochemical pharmacology2008

Dopaminergic signaling in dendritic spines.

Wei-Dong Yao, Roger D Spealman, Jingping Zhang

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Primary cilia and neural computation.Journal of biomedical science · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice.International journal of molecular sciences · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wei-Dong YaoHarvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States. wei-dong_yao@hms.harvard.edu
Roger D Spealman
Jingping Zhang
Harvard University · US

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WESTMORELAND, SUSAN V. · 1985 to 2011
$139.3M
Nonhuman Primate Models of Speedball AbuseR01DA011928 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SPEALMAN, ROGER D · 1998 to 2007
$2.5M
Strategies for Enhancing Extinction of Drug-Seeking BehaviorR01DA024315 · NIDA · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KANTAK, KATHLEEN M. · 2007 to 2011
$1.9M
mGluR5 Mechanisms in Primate Models of Cocaine AbuseR01DA017700 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SPEALMAN, ROGER D · 2004 to 2008
$1.8M
Molecular and Genetic Adaptations Associated with Compulsive Cocaine IntakeR01DA021420 · NIDA · HARVARD MEDICAL SCHOOL · PI YAO, WEI-DONG · 2007 to 2010
$1.5M
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
PSD-95 in Striatal Neuronal VulnerabilityR21NS057311 · NINDS · HARVARD MEDICAL SCHOOL · PI YAO, WEI-DONG · 2008 to 2009
$417k
NCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000168NCRR NIH HHS RR000168NIDA NIH HHS DA011059NIDA NIH HHS DA011928NIDA NIH HHS DA017700NIDA NIH HHS DA021420NIDA NIH HHS DA024315NIDA NIH HHS R01 DA011928NIDA NIH HHS R01 DA017700NIDA NIH HHS R01 DA021420NIDA NIH HHS R01 DA024315NINDS NIH HHS NS057311NINDS NIH HHS R21 NS057311
6 · The paper itself

Abstract

Dopamine regulates movement, motivation, reward, and learning and is implicated in numerous neuropsychiatric and neurological disorders. The action of dopamine is mediated by a family of seven-transmembrane G protein-coupled receptors encoded by at least five dopamine receptor genes (D1, D2, D3, D4, and D5), some of which are major molecular targets for diverse neuropsychiatric medications. Dopamine receptors are present throughout the soma and dendrites of the neuron, but accumulating ultrastructural and biochemical evidence indicates that they are concentrated in dendritic spines, where most of the glutamatergic synapses are established. By modulating local channels, receptors, and signaling modules in spines, this unique population of postsynaptic receptors is strategically positioned to control the excitability and synaptic properties of spines and mediate both the tonic and phasic aspects of dopaminergic signaling with remarkable precision and versatility. The molecular mechanisms that underlie the trafficking, targeting, anchorage, and signaling of dopamine receptors in spines are, however, largely unknown. The present commentary focuses on this important subpopulation of postsynaptic dopamine receptors with emphases on recent molecular, biochemical, pharmacological, ultrastructural, and physiological studies that provide new insights about their regulatory mechanisms and unique roles in dopamine signaling.

Indexed as

AnimalsCell MembraneDendritic SpinesDopamineNeuronal PlasticityReceptors, DopamineSignal TransductionSynapsesDopamineReceptors, Dopamine

Identifiers

PMID18353279
PMCPMC2443745
OpenAlexW2160603112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.